Cas:3646-50-2 3 Amino-phenylpropionic acid manufacturer & supplier

Chemical Name:3 Amino-phenylpropionic acid

CAS.NO:3646-50-2

Synonyms:3-phenyl-3-aminopropionic acid;3-amino-3-phenyl-propionic acid;Dl-3-Amino-3-Phenylpropionic Acid;3 Amino-phenylpropionic acid;3-Amino-3-phenylpropanoic acid;3-azanyl-3-phenyl-propanoic acid;Benzenepropanoic acid, β-amino-;3-phenyl-3-aminopropanoic acid

Molecular Formula:C₉H₁₁NO₂

Molecular Weight:165.189

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:307.5±30.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.575

PSA:63.32000

Exact Mass:165.078979

LogP:0.91

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-phenyl-3-aminopropionic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-phenyl-3-aminopropanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-phenyl-3-aminopropanoic acid Use and application,Dl-3-Amino-3-Phenylpropionic Acid technical grade,usp/ep/jp grade.

Related News: Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. 3 Amino-phenylpropionic acid manufacturer Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. 3 Amino-phenylpropionic acid supplier ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials. 3 Amino-phenylpropionic acid vendor Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. 3 Amino-phenylpropionic acid factory As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.